James M Balwit

519 total citations
7 papers, 403 citations indexed

About

James M Balwit is a scholar working on Oncology, Immunology and Infectious Diseases. According to data from OpenAlex, James M Balwit has authored 7 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in James M Balwit's work include Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers) and Microbial Metabolism and Applications (2 papers). James M Balwit is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers) and Microbial Metabolism and Applications (2 papers). James M Balwit collaborates with scholars based in United States, Netherlands and Germany. James M Balwit's co-authors include Richard A. Proctor, Petra van Langevelde, James M. Vann, Ómar Vesga, Steven K. Burke, Maureen Dillon, Francesco M. Marincola, Patrick Hwu, Walter J. Urba and Thomas F. Gajewski and has published in prestigious journals such as The Journal of Infectious Diseases, Journal of Translational Medicine and Therapy.

In The Last Decade

James M Balwit

6 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James M Balwit United States 5 215 195 65 62 51 7 403
Lucía Rossi Italy 11 199 0.9× 154 0.8× 70 1.1× 44 0.7× 17 0.3× 23 465
Yi Tian Ting Australia 12 70 0.3× 133 0.7× 57 0.9× 40 0.6× 111 2.2× 20 402
J. Verhoef Netherlands 8 111 0.5× 79 0.4× 114 1.8× 11 0.2× 100 2.0× 15 391
Christine Dieterich United States 10 96 0.4× 77 0.4× 147 2.3× 43 0.7× 76 1.5× 12 492
Katja G. Weinacht United States 8 152 0.7× 321 1.6× 69 1.1× 121 2.0× 149 2.9× 13 573
Monia Khémiri Tunisia 10 75 0.3× 72 0.4× 41 0.6× 31 0.5× 63 1.2× 42 302
Camilla Riva Italy 12 108 0.5× 269 1.4× 125 1.9× 32 0.5× 71 1.4× 20 578
A. D. Phillips United Kingdom 10 107 0.5× 61 0.3× 73 1.1× 99 1.6× 73 1.4× 16 425
Roberto A. Chavez United States 7 58 0.3× 270 1.4× 35 0.5× 15 0.2× 127 2.5× 7 380
Atsuko Hayashida United States 7 106 0.5× 165 0.8× 31 0.5× 15 0.2× 75 1.5× 11 358

Countries citing papers authored by James M Balwit

Since Specialization
Citations

This map shows the geographic impact of James M Balwit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M Balwit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M Balwit more than expected).

Fields of papers citing papers by James M Balwit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M Balwit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M Balwit. The network helps show where James M Balwit may publish in the future.

Co-authorship network of co-authors of James M Balwit

This figure shows the co-authorship network connecting the top 25 collaborators of James M Balwit. A scholar is included among the top collaborators of James M Balwit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M Balwit. James M Balwit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Balwit, James M, Paweł Kaliński, Vernon K. Sondak, et al.. (2011). Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer. Journal of Translational Medicine. 9(1). 60–60. 4 indexed citations
2.
Balwit, James M, Patrick Hwu, Walter J. Urba, & Francesco M. Marincola. (2011). The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program. Journal of Translational Medicine. 9(1). 18–18. 14 indexed citations
3.
Bedognetti, Davide, James M Balwit, Ena Wang, et al.. (2011). SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: Online resources and useful tools - a compass in the land of biomarker discovery. Journal of Translational Medicine. 9(1). 155–155. 24 indexed citations
4.
Bleyer, Anthony J. & James M Balwit. (2005). Sevelamer hydrochloride: a calcium- and metal-free phosphate binder. Therapy. 2(6). 823–834. 2 indexed citations
5.
Burke, Steven K., et al.. (2003). Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients. Advances in Renal Replacement Therapy. 10(2). 133–145. 52 indexed citations
6.
Proctor, Richard A., James M Balwit, & Ómar Vesga. (1994). Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections.. PubMed. 3(6). 302–12. 112 indexed citations
7.
Balwit, James M, Petra van Langevelde, James M. Vann, & Richard A. Proctor. (1994). Gentamicin-Resistant Menadione And Hemin Auxotrophic Staphylococcus Aureus Persist Within Cultured Endothelial Cells. The Journal of Infectious Diseases. 170(4). 1033–1037. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026